Fibrates and Statins in the Treatment of Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 396-405

Bentham Science Publishers

Access to resources Recommend Favorite

Confronting the Residual Cardiovascular Risk Beyond Statins: The Role of Fibrates, Omega-3 Fatty Acids, or Niacin, in Diabetic Patients

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3675-3688

Bentham Science Publishers

Access to resources Recommend Favorite

Psychiatric Adverse Reactions with Statins, Fibrates and Ezetimibe: Implications for the Use of Lipid-Lowering Agents

By Tatley Michael   Savage Ruth  

Drug Safety, Vol. 30, Iss. 3, 2007-01 ,pp. : 195-201

Adis International

Access to resources Recommend Favorite

Is there no limit to the power of statins?

By  

Inpharma, Vol. 1, Iss. 1650, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Role of Statins in Peri-Operative Medicine

By  

Current Drug Targets, Vol. 10, Iss. 9, 2009-09 ,pp. : 850-857

Bentham Science Publishers

Access to resources Recommend Favorite